Laxxon Medical | WebDisclosure

Basculer en Français

8295	Companies
114846	Keywords
55288	Articles
62438	Press releases

Home
Companies
Laxxon Medical

BRIEF

published on 10/09/2024 at 20:06, 1 month 11 days ago

Laxxon Medical to Present SPID® Technology at CPHI Milan 2024

Laxxon Medical Pharmaceutical Manufacturing SPID® Technology CGMP Printing Technology CPHI Milan 2024
PRESS RELEASE

published on 10/09/2024 at 20:01, 1 month 11 days ago

Laxxon Medical to Attend CPHI Milan 2024, Showcasing the cGMP Printing Technology at Adare Pharma Solution’s Facility in Pessano, Italy
Laxxon Medical to showcase cGMP Printing Technology at CPHI Milan 2024, unveiling innovative oral drug delivery systems through SPID® Technology

Laxxon Medical SPID® Technology CGMP Printing CPHI Milan Oral Drug Delivery
BRIEF

published on 10/01/2024 at 15:05, 1 month 19 days ago

Laxxon Medical et Adare Pharma Solutions annoncent une coopération conjointe pour la production de formes posologiques orales imprimées en 3D cGMP en Europe et aux États-Unis

Production CGMP Laxxon Medical Adare Pharma Partenariat Pharmaceutique Médicaments Imprimés En 3D
BRIEF

published on 10/01/2024 at 15:05, 1 month 19 days ago

Laxxon Medical and Adare Pharma Solutions Announce Joint Cooperation for Production of cGMP 3D Printed Oral Dosage Forms in Europe and US

CGMP Production Laxxon Medical Pharma Partnership 3D Printed Drugs Adare Pharma
PRESS RELEASE

published on 10/01/2024 at 15:00, 1 month 19 days ago

Laxxon Medical and Adare Pharma Solutions Announce Joint Cooperation for Production of cGMP 3D Printed Oral Dosage Forms in Europe and US
Laxxon Medical & Adare Pharma Cooperate for cGMP 3D Printed Oral Dosage Forms production in Europe & US. Utilizing SPID® Technology by Laxxon & Adare's cGMP-certified facilities

Drug Delivery Laxxon Medical 3D Printed Adare Pharma Solutions CGMP
BRIEF

published on 05/22/2024 at 15:10, 5 months 29 days ago

Laxxon Medical Announces Development of Non-Invasive Oral GLP-1 Asset

Obesity Treatment Laxxon Medical GLP-1 Receptor Agonist SPID® Technology 505(b)2 Pathway
BRIEF

published on 05/22/2024 at 15:10, 5 months 29 days ago

Laxxon Medical annonce le développement d'un actif GLP-1 oral non invasif

Laxxon Medical Traitement De L'obésité Agoniste Du Récepteur GLP-1 Technologie SPID® Voie 505(b)2
PRESS RELEASE

published on 05/22/2024 at 15:05, 5 months 29 days ago

Laxxon Medical Announces Development Program for Non-Invasive, 3D Printed Oral GLP-1 Asset, Offering an Alternative to GLP-1 Injections on Market
Laxxon Medical announces development program for LXM.2, a 3D printed oral GLP-1 receptor agonist for obesity treatment, offering an alternative to injections. Utilizes SPID® platform technology for enhanced bioavailability

Obesity Treatment Laxxon Medical GLP-1 LXM.2 3D Printed
BRIEF

published on 05/16/2024 at 15:05, 6 months 4 days ago

Laxxon Medical présentera LXM.2, un nouvel agoniste du GLP-1 imprimé en 3D au BIO 2024

Laxxon Medical Technologie D'impression 3D Innovation Pharmaceutique Agoniste Du GLP-1 Convention Internationale BIO
BRIEF

published on 05/16/2024 at 15:05, 6 months 4 days ago

Laxxon Medical to Showcase LXM.2, a Novel 3D Printed GLP-1 Agonist at BIO 2024

3D Printing Technology BIO International Convention Laxxon Medical Pharmaceutical Innovation GLP-1 Agonist

Accesswire

Published on 11/21/2024 at 10:03, 1 hour 36 minutes ago

Pixotope Launches Revolutionary AI-Powered Graphics Integration Tool for Broadcast Industry
Published on 11/21/2024 at 10:00, 1 hour 39 minutes ago

BluSky Carbon JV Entity BluMountain Enters into JV Partnership in Southeastern USA
Published on 11/21/2024 at 09:00, 2 hours 39 minutes ago

ProScore Announces Domestic Content Solution for Inflation Reduction Act Requirements
Published on 11/21/2024 at 00:35, 11 hours 4 minutes ago

Vision Marine Technologies Establishes a Strategic Hub for Electric Boat Sales, Rentals, and Distribution, Marking a Milestone at Dania Pointe’s Grand Opening of Aileron Residences
Published on 11/21/2024 at 00:25, 11 hours 14 minutes ago

Biomind Labs Welcomes U.S. Policy Shift as a Historic Milestone for Psychedelic Therapies

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 11:01, 37 minutes ago

Original-Research: SMT Scharf AG (von Montega AG): Kaufen
Published on 11/21/2024 at 11:00, 39 minutes ago

First Patient Treated in Phase I/II Trial in Acute Myeloid and Acute Lymphoblastic Leukemia with Lu177-PentixaTher, Expanding the Evidence Base for Targeted Radiotherapy Approach
Published on 11/21/2024 at 10:56, 42 minutes ago

ABO Energy closes sale for two Battery Projects in South Africa
Published on 11/21/2024 at 10:30, 1 hour 9 minutes ago

MS Industrie AG publishes unaudited key figures for the first 3 quarters 2024
Published on 11/21/2024 at 10:04, 1 hour 34 minutes ago

Supervisory Board appoints Carsten Schmitt as new CFO

Les Echos

Published on 11/21/2024 at 06:58, 4 hours 41 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 4 hours 41 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 4 hours 41 minutes ago

Netto-actiefwaarde per aandeel stijgt in zes maanden met 9,4% tot EUR 55,6 dankzij aanhoudend sterke groeiprestaties van portefeuille
Published on 11/20/2024 at 20:07, 15 hours 31 minutes ago

Entech : Nouveaux objectifs stratégiques à moyen-terme et Chiffre d’Affaires du 1er semestre 2024
Published on 11/20/2024 at 19:20, 16 hours 19 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting

View all LES ECHOS COMFI WIRE